COVID-19: US panel recommends resuming Johnson & Johnson vaccine

·1-min read

A US medical panel has recommended resuming the use of the Johnson & Johnson COVID-19 vaccine.

The recommendation came from advisers to the US Centers for Disease Control and Prevention (CDC).

The vaccine was paused by the CDC and US Food and Drug Administration last week after reports of rare but serious blood clots associated with low blood platelets.

The Johnson & Johnson vaccine, which is given as a single jab as opposed to the traditional two doses, has been administered to almost eight million people in the US.

It has not been approved for use in the UK, but the government has ordered 30 million doses.